Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bioventus (BVS) FCF Margin (2020 - 2025)

Historic FCF Margin for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to 21.37%.

  • Bioventus' FCF Margin rose 139900.0% to 21.37% in Q3 2025 from the same period last year, while for Sep 2025 it was 9.48%, marking a year-over-year increase of 42500.0%. This contributed to the annual value of 6.59% for FY2024, which is 46100.0% up from last year.
  • Bioventus' FCF Margin amounted to 21.37% in Q3 2025, which was up 139900.0% from 17.1% recorded in Q2 2025.
  • In the past 5 years, Bioventus' FCF Margin registered a high of 21.37% during Q3 2025, and its lowest value of 23.74% during Q2 2021.
  • Moreover, its 5-year median value for FCF Margin was 6.86% (2023), whereas its average is 2.22%.
  • As far as peak fluctuations go, Bioventus' FCF Margin crashed by -458500bps in 2021, and later surged by 213700bps in 2023.
  • Over the past 5 years, Bioventus' FCF Margin (Quarter) stood at 3.19% in 2021, then soared by 159bps to 8.27% in 2022, then decreased by -11bps to 7.39% in 2023, then soared by 65bps to 12.2% in 2024, then soared by 75bps to 21.37% in 2025.
  • Its last three reported values are 21.37% in Q3 2025, 17.1% for Q2 2025, and 16.27% during Q1 2025.